<DOC>
	<DOCNO>NCT00003611</DOCNO>
	<brief_summary>RATIONALE : Chemoprevention therapy use certain drug try prevent development recurrence cancer . The use acitretin may effective way prevent recurrence development skin cancer . PURPOSE : Randomized clinical trial study effectiveness acitretin prevent skin cancer patient least two previously treat skin cancer undergo organ transplantation .</brief_summary>
	<brief_title>Acitretin Preventing Skin Cancers Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation</brief_title>
	<detailed_description>OBJECTIVES : - Determine chemopreventive efficacy acitretin immunosuppressed solid organ transplant recipient history multiple previous basal cell carcinoma ( BCC ) squamous cell carcinoma ( SCC ) skin cancer resection . - Evaluate human papillomavirus ( HPV ) possible etiologic cofactor development cutaneous epidermal dysplasia/carcinoma skin tissue patient . - Determine effect acitretin potential surrogate endpoint biomarkers HPV DNA normal ( sun protect ) , sun-exposed , dysplastic carcinoma ( SCC/BCC ) skin specimen . OUTLINE : This randomize study . Patients stratify accord age ( least 18 50 v 50 59 v 60 69 v 70 ) , number prior skin cancer past 5 year ( 2 vs 3 v least 4 ) , time since recent skin cancer occurrence ( le 12 month v least 12 month ) , sunburn susceptibility ( none v moderate v high ) , visible skin damage ( mild v moderate v severe ) . Patients receive either oral acitretin placebo daily 2 year . Skin biopsy obtain 1 year normal area area skin cancer genetic study . Patients follow every 6 month .</detailed_description>
	<mesh_term>Skin Neoplasms</mesh_term>
	<mesh_term>Acitretin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Solid organ recipient ( kidney , liver , heart , lung , pancreas ) receive immunosuppressive agent ( e.g. , prednisone , corticosteroid , azathioprine , cyclosporine , tacrolimus , mycophenolate mofetil ) At least 6 month since transplant At least 2 prior ( event separate event ) basal cell carcinoma ( BCC ) squamous cell carcinoma ( SCC ) resect All visible BCC SCC resect PATIENT CHARACTERISTICS : Age : 18 Life expectancy : Greater 2 year Hematopoietic : WBC least 3400/mm^3 Platelet count least 100,000/mm^3 Hemoglobin least 10.0 g/dL Hepatic : Bilirubin great 1.5 time upper limit normal ( ULN ) Alkaline phosphatase great 3 time ULN SGOT great 3 time ULN Renal : Creatinine great 1.5 time ULN Other : Not pregnant nursing Fertile patient must use two effective form birth control least 1 month , , least 3 year study No history oral retinoid intolerance No significant , uncontrolled hyperlipidemia No significant medical condition threaten allograft rejection state retinoid use would contraindicate PRIOR CONCURRENT THERAPY : Other : At least 1 year since prior retinoids No concurrent oral vitamin A supplement , topical retinoids , potentially irritate skin preparation No alcohol 2 month study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>basal cell carcinoma skin</keyword>
	<keyword>squamous cell carcinoma skin</keyword>
</DOC>